Is Asthma Triple Therapy Effective in Patients With High Baseline SABA Use?
Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?
Treatments
Fluticasone Furoate/Umeclidinium/Vilanterol Therapy and COPD Exacerbations
Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA?
NAVIGATOR Trial Outcomes for Tezepelumab Use in Severe, Uncontrolled Asthma
An analysis of NAVIGATOR trial data on tezepelumab use assessed patient-reported outcomes related to asthma control, symptoms, and HRQoL.
Tezepelumab Improves Lung Function in Severe, Uncontrolled Asthma
NAVIGATOR trial results presented at CHEST 2021 show the effect of tezepelumab on peak expiratory flow rates in severe asthma.
Dupilumab Improves Severe Asthma Outcomes, Regardless of Baseline OCS Dose
A post-hoc analysis of the VENTURE trial evaluated whether baseline oral corticosteroid dosage affected the efficacy of dupilumab in improving severe asthma outcomes.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Integrative Medicine Model Shows Efficacy in Improving MS Treatment
Study demonstrated efficacy in improving communication with the clinician, lowering the number of visits, and improving the coordination of single-day multi-service and therapeutic interventions in multiple sclerosis
Siponimod Treatment for Secondary Progressive MS: Neurologist Expectations
Investigators hypothesize siponimod will function as an alternative therapeutic choice to monoclonal antibodies in MS.
